First Time Loading...

Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 35.68 USD -2.73% Market Closed
Updated: Jun 1, 2024

Rhythm Pharmaceuticals Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rhythm Pharmaceuticals Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Other Liabilities
$35.5m
CAGR 3-Years
146%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.8B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$3.4B
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
24%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$6.3B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.2B
CAGR 3-Years
23%
CAGR 5-Years
51%
CAGR 10-Years
33%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.1B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
18%

See Also

What is Rhythm Pharmaceuticals Inc's Other Liabilities?
Other Liabilities
35.5m USD

Based on the financial report for Mar 31, 2024, Rhythm Pharmaceuticals Inc's Other Liabilities amounts to 35.5m USD.

What is Rhythm Pharmaceuticals Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
60%

Over the last year, the Other Liabilities growth was 1 381%. The average annual Other Liabilities growth rates for Rhythm Pharmaceuticals Inc have been 146% over the past three years , 60% over the past five years .